Matches in Nanopublications for { ?s ?p "[We recommend that HNF4A sequencing is considered in all patients with diazoxide responsive HH diagnosed in the first week of life irrespective of a family history of diabetes, once K(ATP) channel mutations have been excluded.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP367586.RAvasDxik78fC2Zv91hc7vnYC8Y9RiVVrDF_RxW3t0Kig130_assertion description "[We recommend that HNF4A sequencing is considered in all patients with diazoxide responsive HH diagnosed in the first week of life irrespective of a family history of diabetes, once K(ATP) channel mutations have been excluded.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367586.RAvasDxik78fC2Zv91hc7vnYC8Y9RiVVrDF_RxW3t0Kig130_provenance.
- assertion description "[We recommend that HNF4A sequencing is considered in all patients with diazoxide responsive HH diagnosed in the first week of life irrespective of a family history of diabetes, once K(ATP) channel mutations have been excluded.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We recommend that HNF4A sequencing is considered in all patients with diazoxide responsive HH diagnosed in the first week of life irrespective of a family history of diabetes, once K(ATP) channel mutations have been excluded.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We recommend that HNF4A sequencing is considered in all patients with diazoxide responsive HH diagnosed in the first week of life irrespective of a family history of diabetes, once K(ATP) channel mutations have been excluded.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP794438.RAn0GLoE0WSR28C65suE9vlNzfA3rSb5TtU1JU9iKdWo4130_assertion description "[We recommend that HNF4A sequencing is considered in all patients with diazoxide responsive HH diagnosed in the first week of life irrespective of a family history of diabetes, once K(ATP) channel mutations have been excluded.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794438.RAn0GLoE0WSR28C65suE9vlNzfA3rSb5TtU1JU9iKdWo4130_provenance.
- NP794439.RAht2mls2UVcBon9zCV40YojQuuf1RZMy8BZ4EhQVbrms130_assertion description "[We recommend that HNF4A sequencing is considered in all patients with diazoxide responsive HH diagnosed in the first week of life irrespective of a family history of diabetes, once K(ATP) channel mutations have been excluded.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794439.RAht2mls2UVcBon9zCV40YojQuuf1RZMy8BZ4EhQVbrms130_provenance.